ストックスクリーナーアプリを入手
104.75
0.26%
-0.27
Nuvalent Inc (NUVL) 最新ニュース
Nuvalent (NUVL) CSO Pelish sells $323k in shares By Investing.com - Investing.com India
Nuvalent (NUVL) CSO Pelish sells $323k in shares - Investing.com
Nuvalent (NUVL) CSO Pelish exercises options, sells 3,093 shares under plan - Stock Titan
(NUVL) Volatility Zones as Tactical Triggers - Stock Traders Daily
Nuvalent, Inc. (NASDAQ:NUVL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Portfolio Update: Is Nuvalent Inc in a consolidation phase2026 Market Mood & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
What Nuvalent (NUVL)'s FDA NDA Filing for Neladalkib in ALK-Positive NSCLC Means For Shareholders - simplywall.st
Nuvalent CEO Sells Over $3 Million in Stock - National Today
Nuvalent (NUVL) CEO trades 30K shares after option exercises - Stock Titan
Wedbush Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $125 - Moomoo
Nuvalent Submits NDA for Neladalkib in ALK+ NSCLC After TKIs - Oncology Nursing News
LifeSci Capital Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $142 - Moomoo
Nuvalent Announces Submission of New Drug Application to FDA for - GuruFocus
Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC - The Malaysian Reserve
Nuvalent Files FDA Application for Lung Cancer Therapy - TipRanks
Nuvalent Submits New Drug Application to FDA for Neladalkib in Advanced ALK-Positive Lung Cancer - Minichart
Nuvalent submits new drug application to FDA for neladalkib in advanced lung cancer - Investing.com
Nuvalent Announces Submission Of New Drug Application To FDA For Neladalkib In Tki Pre-Treated Advanced Alk-Positive Nsclc - TradingView — Track All Markets
Nuvalent (NUVL) submits FDA New Drug Application for neladalkib in ALK+ lung cancer - Stock Titan
Aberdeen Group plc Increases Holdings in Nuvalent, Inc. $NUVL - MarketBeat
Truist Financial Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $140 - Moomoo
NUVL PE Ratio & Valuation, Is NUVL Overvalued - Intellectia AI
Nuvalent CFO Sells $1.2M in Shares - National Today
Nuvalent (NASDAQ:NUVL) CFO Alexandra Balcom Sells 11,430 Shares - MarketBeat
Nuvalent (NUVL) CFO sells 11,430 shares after option exercise under 10b5-1 plan - Stock Titan
[Form 4] Nuvalent, Inc. Insider Trading Activity - Stock Titan
Wells Fargo Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $116 - Moomoo
Nuvalent Insider Sold Shares Worth $537,943, According to a Recent SEC Filing - marketscreener.com
Nuvalent (NUVL) CDO exercises options, sells 5,500 shares under 10b5-1 plan - Stock Titan
Goldman Sachs Maintains Nuvalent (NUVL) Buy Recommendation - MSN
Stifel Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $135 - moomoo.com
Price-Driven Insight from (NUVL) for Rule-Based Strategy - Stock Traders Daily
Stifel reiterates Buy rating on Nuvalent stock ahead of ROS1 launch - Investing.com Australia
Stifel reiterates Buy rating on Nuvalent stock ahead of ROS1 launch By Investing.com - Investing.com South Africa
22,000 Class A shares proposed sale — NUVL (NASDAQ: NUVL) - Stock Titan
Nuvalent Insider Sold Shares Worth $542,991, According to a Recent SEC Filing - marketscreener.com
Nuvalent (NUVL) CLO exercises 5.5K options, sells 5.5K shares under 10b5-1 - Stock Titan
Nuvalent Initiated at Overweight by Wells Fargo - Moomoo
Wells Fargo initiates Nuvalent stock with overweight rating on drug potential By Investing.com - in.investing.com
Wells Fargo initiates Nuvalent stock with overweight rating on drug potential - Investing.com India
Nuvalent (NASDAQ:NUVL) Earns Overweight Rating from Analysts at Wells Fargo & Company - MarketBeat
Wells Fargo Initiates Nuvalent at Overweight With $116 Price Target - marketscreener.com
Wells Fargo Initiates Nuvalent(NUVL.US) With Buy Rating, Announces Target Price $116 - Moomoo
Upcoming AACR 2026 event announcement sees Nuvalent stock down 1.43% - Traders Union
Weekly Trades: Should I set a stop loss on Nuvalent IncQuarterly Trade Summary & Expert Curated Trade Setups - baoquankhu1.vn
Vanguard disaggregates holdings after realignment; Nuvalent (NUVL) ownership listed as 0 - Stock Titan
Nuvalent (NUVL) CFO sells 25,130 shares in Rule 10b5-1 trades - stocktitan.net
S&P 500 Futures Drop In Premarket Trading; Nuvalent, Figure Tech Solns Lead - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), TELA Bio (TELA) and Nuvalent (NUVL) - The Globe and Mail
NUVL (NASDAQ: NUVL) files Form 144 to sell Class A shares via J.P. Morgan - Stock Titan
ALK-Positive NSCLC Pipeline Gains Momentum as 6+ Pharma Companies Advance Next-Generation Therapies | DelveInsight - Barchart.com
Hudson Bay Capital Management LP Acquires Stake in Nuvalent, Inc. - National Today
Hudson Bay Capital Management LP Purchases New Stake in Nuvalent, Inc. $NUVL - MarketBeat
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally - AOL.com
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):